These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28444149)

  • 1. First 2 Extensively Drug-Resistant Tuberculosis Cases From Myanmar Treated With Bedaquiline.
    Aung HL; Nyunt WW; Fong Y; Cook GM; Aung ST
    Clin Infect Dis; 2017 Aug; 65(3):531-532. PubMed ID: 28444149
    [No Abstract]   [Full Text] [Related]  

  • 2. Emergence of Low-level Delamanid and Bedaquiline Resistance During Extremely Drug-resistant Tuberculosis Treatment.
    Polsfuss S; Hofmann-Thiel S; Merker M; Krieger D; Niemann S; Rüssmann H; Schönfeld N; Hoffmann H; Kranzer K
    Clin Infect Dis; 2019 Sep; 69(7):1229-1231. PubMed ID: 30933266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent acquisition of bedaquiline resistance by epidemic extensively drug-resistant Mycobacterium tuberculosis strains in Russia during long-term treatment.
    Mokrousov I; Akhmedova G; Molchanov V; Fundovnaya E; Kozlova E; Ostankova Y; Semenov A; Maslennikova N; Leontev D; Zhuravlev V; Turkin E; Vyazovaya A
    Clin Microbiol Infect; 2021 Mar; 27(3):478-480. PubMed ID: 32891766
    [No Abstract]   [Full Text] [Related]  

  • 4. Bedaquiline susceptibility test for totally drug-resistant tuberculosis Mycobacterium tuberculosis.
    Jang JC; Jung YG; Choi J; Jung H; Ryoo S
    J Microbiol; 2017 Jun; 55(6):483-487. PubMed ID: 28429168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline.
    Tadolini M; Lingtsang RD; Tiberi S; Enwerem M; D'Ambrosio L; Sadutshang TD; Centis R; Migliori GB
    Eur Respir J; 2016 Sep; 48(3):935-8. PubMed ID: 27288039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman.
    Jaspard M; Elefant-Amoura E; Melonio I; De Montgolfier I; Veziris N; Caumes E
    Emerg Infect Dis; 2017 Oct; 23(10):1731-2. PubMed ID: 28792382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First use of bedaquiline in a patient with XDR-TB in Singapore.
    Chua AP; Hoo GS; Chee CB; Wang YT
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26400590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensively drug-resistant tuberculosis: early access to bedaquiline for a UK patient.
    van Halsema C; Humphreys S; Bonington A
    Eur Respir J; 2014 Jan; 43(1):292-4. PubMed ID: 23988770
    [No Abstract]   [Full Text] [Related]  

  • 9. Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort.
    Guglielmetti L; Le Dû D; Jachym M; Henry B; Martin D; Caumes E; Veziris N; Métivier N; Robert J;
    Clin Infect Dis; 2015 Jan; 60(2):188-94. PubMed ID: 25320286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bedaquiline in MDR/XDR-TB cases: first experience on compassionate use.
    Tiberi S; De Lorenzo S; Centis R; Viggiani P; D'Ambrosio L; Migliori GB
    Eur Respir J; 2014 Jan; 43(1):289-92. PubMed ID: 23988772
    [No Abstract]   [Full Text] [Related]  

  • 11. Bedaquiline plus delamanid for XDR tuberculosis.
    Lachâtre M; Rioux C; Le Dû D; Fréchet-Jachym M; Veziris N; Bouvet E; Yazdanpanah Y
    Lancet Infect Dis; 2016 Mar; 16(3):294. PubMed ID: 26973310
    [No Abstract]   [Full Text] [Related]  

  • 12. Easier cure for resistant TB.
    Cohen J
    Science; 2017 Feb; 355(6326):677. PubMed ID: 28209851
    [No Abstract]   [Full Text] [Related]  

  • 13. Early access to bedaquiline for extensively drug-resistant (XDR) and pre-XDR tuberculosis.
    Vasilyeva I; Mariandyshev A; Kazennyy B; Davidavičienė E; Lounis N; Keim S;
    Eur Respir J; 2019 Jul; 54(1):. PubMed ID: 31097518
    [No Abstract]   [Full Text] [Related]  

  • 14. Acquisition of bedaquiline resistance by extensively drug-resistant Mycobacterium tuberculosis strain of Central Asian Outbreak clade.
    Mokrousov I; Akhmedova G; Polev D; Molchanov V; Vyazovaya A
    Clin Microbiol Infect; 2019 Oct; 25(10):1295-1297. PubMed ID: 31229592
    [No Abstract]   [Full Text] [Related]  

  • 15. Bedaquiline: a novel antitubercular drug for multidrug-resistant tuberculosis.
    Nagabushan H; Roopadevi HS
    J Postgrad Med; 2014; 60(3):300-2. PubMed ID: 25121373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extensively drug-resistant tuberculosis treated with bedaquiline].
    López Pérez A; Navarro Aznarez H; Pinilla Rello A; Perales Pascual J; Arazo Garcés P
    Rev Esp Quimioter; 2023 Apr; 36(2):201-202. PubMed ID: 36588483
    [No Abstract]   [Full Text] [Related]  

  • 17. Population implications of the use of bedaquiline in people with extensively drug-resistant tuberculosis: are fears of resistance justified?
    Kunkel A; Furin J; Cohen T
    Lancet Infect Dis; 2017 Dec; 17(12):e429-e433. PubMed ID: 28533094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compassionate use of bedaquiline in the treatment of pulmonary XDR-TB.
    Danckers M; Lesko MB; Adamson R; Leibert E
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1522-3. PubMed ID: 25517823
    [No Abstract]   [Full Text] [Related]  

  • 19. Delamanid and Bedaquiline Resistance in Mycobacterium tuberculosis Ancestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee.
    Hoffmann H; Kohl TA; Hofmann-Thiel S; Merker M; Beckert P; Jaton K; Nedialkova L; Sahalchyk E; Rothe T; Keller PM; Niemann S
    Am J Respir Crit Care Med; 2016 Feb; 193(3):337-40. PubMed ID: 26829425
    [No Abstract]   [Full Text] [Related]  

  • 20. Landmark legal ruling sees Indian girl prescribed bedaquiline for XDR-TB.
    Kirby T
    Lancet Respir Med; 2017 Apr; 5(4):249. PubMed ID: 28169199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.